🩺 Lilly-Backed TRex Bio Closes Flat at $14 After $117M IPO

Eli Lilly-backed TRex Bio closed its first trading day flat at its $14 IPO price, raising $117M. Shares opened at $13.50, dipped below $14, spiked to $15.50 late, then settled.

#LLY #IPO #Lilly

https://financier.news/

👋 Andrea Ravalli · eToro Popular Investor

📊 Long-Term Multi-Asset Strategy:
• +190% cumulative return since 2020 (~17% CAGR)
• 3/10 Risk Score · 0% Leverage (1x real assets)
• Core: Healthcare & Biotech

#FinSky #Investing $LLY ABBV NOVO #Healthcare #Biotech #Dividends

💊 Eli Lilly GLP-1 Franchise Hits $15.7B Revenue, Growing 76% as Stock Slips

Mounjaro and Zepbound now generate $15.7B in combined revenue, up 76%, keeping Eli Lilly's weight-loss franchise the sector's dominant money machine.

#LLY #Lilly

https://financier.news/

$101M of options premium hit $LLY by the close, calls carried 72% of it. The Oct 9 expiry took 45%. Biggest line was the Oct 23 910 calls with $2.44M. Call heavy flow leaning against the tape, shares are down 2%. Dealers sit long gamma, so their hedging leans against moves.

$HD options took in $29.4M by the close, 3.2x its recent average of $9.31M a session, close to even at 52% calls. 44% sat in the Oct 16 expiry, led by the 330 puts with $3.76M. The stock is up 3.2%. Dealers are long gamma, so hedging tends to fade a move. $LLY in the thread.

🌆 US Market Close · 07 Oct 2026
⚖️ Portfolio: -0.38% (+200% since 2020)

📈 Movers: ▲ $NOVO-B.CO +3.4% · ▲ $LLY +2.7% · ▲ $AZN.L +1.9%

💬 What's your highest conviction tech or energy play for 2026?
#FinSky #Investing #Stocks #AI #Portfolio

Eli Lilly groeit sterk, maar valuation laat geen ruimte voor teleurstellingen

Eli Lilly presteert als groeibedrijf u…

https://yieldgraph.nl/blog/eli-lilly-groeit-sterk-maar-valuation-laat-geen-ruimte-voor-teleurstellingen/ #aandelen #beleggen #investeren #beursnieuws #lly #WallStreet #YieldGraph

$LLY options took in $37.5M in the first 15 minutes, already 1.1x its recent average session of $35.3M, close to even at 43% calls. Biggest line was the Oct 23 910 calls with $2.44M. Shares are down 0.79%. Dealers are short gamma, so hedging can extend a move. $WMT below.

👋 Andrea Ravalli · eToro Popular Investor

📊 Long-Term Multi-Asset Strategy:
• +190% cumulative return since 2020 (~17% CAGR)
• 3/10 Risk Score · 0% Leverage (1x real assets)
• Core: Healthcare & Biotech

#FinSky #Investing $LLY ABBV NOVO #Healthcare #Biotech #Dividends

Roche's obesitasmiddel onder druk zetten concurrentie LLY en Novo

Roche's experimentele obesitasmiddel enicepatide toont veel…

https://yieldgraph.nl/blog/roches-obesitasmiddel-onder-druk-zetten-concurrentie-lly-en-novo/ #investeren #financien #beurs #financieelnieuws #lly #WallStreet #YieldGraph

$22M of premium on $LLY across 21 unusual strikes, led by call buyers, put call ratio 0.85.

Standout was the Oct 30 975 calls with $957k at 43x OI.

Dealers sit long gamma, so strength tends to stall. Skew leans to puts, and vol trades rich to realized.

Loud strikes on the US tape for the Sep 28 session.

$19M on $COST across 15 unusual strikes, calls leading.
$22M on $LLY across 21 unusual strikes, calls leading.

Dealers lean against both names, so the flow could get faded.

Strikes for each name in the replies.

$LLY JPMorgan raises price target to $1,500 from $1,400, maintains Overweight.

- Analyst sees strong incretin trends continuing
- Expects Lilly to raise guidance again after Q3 results
- PT implies significant upside from current levels

#LLY

🇺🇸 FDA Clears Eli Lilly's Olumiant for Teens 12+ With Severe Alopecia Areata

The FDA expanded Olumiant's label to treat severe alopecia areata in patients 12 and older, widening the baricitinib market beyond adults.

#LLY #EliLilly #Equities

Eli Lilly stijgt na FDA-goedkeuring insulin Onswik

Aandelen van farmabedrijf Eli Lilly stegen 3,1% na FDA-goedkeuring van het wekelijkse bas…

https://yieldgraph.nl/blog/eli-lilly-stijgt-na-fda-goedkeuring-insulin-onswik/ #investeren #beleggen #beurs #financieelnieuws #lly #WallStreet #YieldGraph

🌆 US Market Close · 24 Sep 2026
⚖️ Portfolio: -0.35% (+200% since 2020)

📈 Movers: ▲ $LLY +2.8% · ▲ $WCLD.L +1.9% · ▲ $1919.HK +1.7%

💬 What's your highest conviction tech or energy play for 2026?
#FinSky #Investing #Stocks #AI #Portfolio

$LLY saw $45M across 24 unusual strikes, led by call buyers, put call ratio 0.61.

Standouts were the Sep 25 895 calls with $2M at 5x OI and the Oct 16 1200 calls with $1.6M.

Long dealer gamma caps the enthusiasm here. Calls carry the skew, and implied sits over realized.

Two names carried the aggressive options flow for the Sep 24 session.

$11M on $HD across 34 unusual strikes, puts leading.
$45M on $LLY across 24 unusual strikes, calls leading.

Dealers back one of the names and lean against one.

More on each name below.

Eli Lilly's Retatrutide kan miljarden waard zijn

Eli Lilly domineert de markt voor gewichtsverlies met Retatrutide, dat mogelijk miljarden dollar…

https://yieldgraph.nl/blog/eli-lillys-retatrutide-kan-miljarden-waard-zijn/ #investeren #beleggen #aandelen #beursnieuws #lly #WallStreet #YieldGraph